Incidence and outcome of lung involvement in  IgG 4‐related autoimmune pancreatitis | Zendy

Ogoshi Takaaki | Zendy; Kido Takashi | Zendy; Yatera Kazuhiro | Zendy; Oda Keishi | Zendy; Nishida Chinatsu | Zendy; Yamasaki Kei | Zendy; Orihashi Takeshi | Zendy; Kawanami Yukiko | Zendy; Ishimoto Hiroshi | Zendy; Taguchi Masashi | Zendy; Harada Masaru | Zendy; Mukae Hiroshi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Incidence and outcome of lung involvement in IgG 4‐related autoimmune pancreatitis

Author(s) -

Ogoshi Takaaki,

Kido Takashi,

Yatera Kazuhiro,

Oda Keishi,

Nishida Chinatsu,

Yamasaki Kei,

Orihashi Takeshi,

Kawanami Yukiko,

Ishimoto Hiroshi,

Taguchi Masashi,

Harada Masaru,

Mukae Hiroshi

Publication year - 2015

Publication title -

respirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.857

H-Index - 85

eISSN - 1440-1843

pISSN - 1323-7799

DOI - 10.1111/resp.12599

Subject(s) - medicine , autoimmune pancreatitis , incidence (geometry) , lung , pancreatitis , gastroenterology , immunology , physics , optics

We evaluated the incidence and outcome of lung involvement in 35 patients with autoimmune pancreatitis ( AIP ). Our results indicate that lung involvement is commonly observed in AIP (40%). In addition, corticosteroid treatment improved the lung lesions and appeared to reduce the probability of relapse compared with pancreatic lesions (0% vs 36%). This is the first report to assess the long‐term outcome of lung involvement in AIP (52 ± 33 months).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research